Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Attenuated plaque at nonculprit lesions in patients enrolled in intravascular ultrasound atherosclerosis progression trials.

Bayturan O, Tuzcu EM, Nicholls SJ, Balog C, Lavoie A, Uno K, Crowe TD, Magyar WA, Wolski K, Kapadia S, Nissen SE, Schoenhagen P.

JACC Cardiovasc Interv. 2009 Jul;2(7):672-8. doi: 10.1016/j.jcin.2009.05.007.

2.

Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.

Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM; ASTEROID Investigators.

JAMA. 2006 Apr 5;295(13):1556-65. Epub 2006 Mar 13.

PMID:
16533939
3.

Effect of statins on coronary bifurcation atherosclerosis: an intravascular ultrasound virtual histology study.

Shin ES, Garcia-Garcia HM, Okamura T, Serruys PW.

Int J Cardiovasc Imaging. 2012 Oct;28(7):1643-52. doi: 10.1007/s10554-011-9989-9. Epub 2011 Dec 18.

PMID:
22179944
4.

Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis.

Hong MK, Park DW, Lee CW, Lee SW, Kim YH, Kang DH, Song JK, Kim JJ, Park SW, Park SJ.

JACC Cardiovasc Interv. 2009 Jul;2(7):679-88. doi: 10.1016/j.jcin.2009.03.015.

5.
6.

Early intervention with rosuvastatin decreases the lipid components of the plaque in acute coronary syndrome: analysis using integrated backscatter IVUS (ELAN study).

Otagiri K, Tsutsui H, Kumazaki S, Miyashita Y, Aizawa K, Koshikawa M, Kasai H, Izawa A, Tomita T, Koyama J, Ikeda U.

Circ J. 2011;75(3):633-41. Epub 2011 Jan 24.

8.

Impact of baseline plaque components on plaque progression in nonintervened coronary segments in patients with angina pectoris on rosuvastatin 10 mg/day.

Hong YJ, Jeong MH, Choi YH, Ma EH, Ko JS, Lee MG, Park KH, Sim DS, Yoon NS, Youn HJ, Kim KH, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC.

Am J Cardiol. 2010 Nov 1;106(9):1241-7. doi: 10.1016/j.amjcard.2010.06.046. Epub 2010 Sep 9.

PMID:
21029819
9.

Coronary plaque characterization of nonculprit or nontarget lesions assessed by analysis of in vivo intracoronary ultrasound radio-frequency data.

Liu HL, Zhang J, Ma DX, Luo JP, Yang SL, Han W, Liu Y, Jing LM, Meng RY.

Chin Med J (Engl). 2009 Mar 20;122(6):622-6.

PMID:
19323923
11.

Effect of fluvastatin on progression of coronary atherosclerotic plaque evaluated by virtual histology intravascular ultrasound.

Nasu K, Tsuchikane E, Katoh O, Tanaka N, Kimura M, Ehara M, Kinoshita Y, Matsubara T, Matsuo H, Asakura K, Asakura Y, Terashima M, Takayama T, Honye J, Hirayama A, Saito S, Suzuki T.

JACC Cardiovasc Interv. 2009 Jul;2(7):689-96. doi: 10.1016/j.jcin.2009.04.016.

12.

Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS).

Takayama T, Hiro T, Yamagishi M, Daida H, Hirayama A, Saito S, Yamaguchi T, Matsuzaki M; COSMOS Investigators.

Circ J. 2009 Nov;73(11):2110-7. Epub 2009 Oct 5.

13.

Comparison of effects of rosuvastatin and atorvastatin on plaque regression in Korean patients with untreated intermediate coronary stenosis.

Hong YJ, Jeong MH, Hachinohe D, Ahmed K, Choi YH, Cho SH, Hwang SH, Ko JS, Lee MG, Park KH, Sim DS, Yoon NS, Yoon HJ, Kim KH, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC.

Circ J. 2011;75(2):398-406. Epub 2010 Dec 9.

14.

Attenuated plaque detected by intravascular ultrasound: clinical, angiographic, and morphologic features and post-percutaneous coronary intervention complications in patients with acute coronary syndromes.

Lee SY, Mintz GS, Kim SY, Hong YJ, Kim SW, Okabe T, Pichard AD, Satler LF, Kent KM, Suddath WO, Waksman R, Weissman NJ.

JACC Cardiovasc Interv. 2009 Jan;2(1):65-72. doi: 10.1016/j.jcin.2008.08.022.

15.

Impact of attenuated plaque as detected by intravascular ultrasound on the occurrence of microvascular obstruction after percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.

Shiono Y, Kubo T, Tanaka A, Tanimoto T, Ota S, Ino Y, Aoki H, Ozaki Y, Orii M, Shimamura K, Ishibashi K, Yamano T, Yamaguchi T, Hirata K, Imanishi T, Akasaka T.

JACC Cardiovasc Interv. 2013 Aug;6(8):847-53. doi: 10.1016/j.jcin.2013.01.142. Epub 2013 Jul 17.

16.

Morphological changes and clinical impact of unstable plaques within untreated segments of acute myocardial infarction patients during a 3-year follow-up: an analysis from the HORIZONS-AMI trial.

Souza CF, Doi H, Mintz GS, Lansky AJ, Witzenbichler B, Guagliumi G, Brodie BR, Kellett MA Jr, Xu K, Mehran R, Stone GW, Maehara A.

Coron Artery Dis. 2015 Sep;26(6):469-75. doi: 10.1097/MCA.0000000000000251.

PMID:
25919902
17.

Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial.

Hirohata A, Yamamoto K, Miyoshi T, Hatanaka K, Hirohata S, Yamawaki H, Komatsubara I, Murakami M, Hirose E, Sato S, Ohkawa K, Ishizawa M, Yamaji H, Kawamura H, Kusachi S, Murakami T, Hina K, Ohe T.

J Am Coll Cardiol. 2010 Mar 9;55(10):976-82. doi: 10.1016/j.jacc.2009.09.062.

18.

Coronary artery calcification and changes in atheroma burden in response to established medical therapies.

Nicholls SJ, Tuzcu EM, Wolski K, Sipahi I, Schoenhagen P, Crowe T, Kapadia SR, Hazen SL, Nissen SE.

J Am Coll Cardiol. 2007 Jan 16;49(2):263-70. Epub 2006 Nov 9.

19.

The relationship between attenuated plaque identified by intravascular ultrasound and no-reflow after stenting in acute myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.

Wu X, Mintz GS, Xu K, Lansky AJ, Witzenbichler B, Guagliumi G, Brodie B, Kellett MA Jr, Dressler O, Parise H, Mehran R, Stone GW, Maehara A.

JACC Cardiovasc Interv. 2011 May;4(5):495-502. doi: 10.1016/j.jcin.2010.12.012.

20.

Comparison of effects of atorvastatin (20 mg) versus rosuvastatin (10 mg) therapy on mild coronary atherosclerotic plaques (from the ARTMAP trial).

Lee CW, Kang SJ, Ahn JM, Song HG, Lee JY, Kim WJ, Park DW, Lee SW, Kim YH, Park SW, Park SJ.

Am J Cardiol. 2012 Jun 15;109(12):1700-4. doi: 10.1016/j.amjcard.2012.01.399. Epub 2012 Mar 20.

PMID:
22440123
Items per page

Supplemental Content

Write to the Help Desk